May 12, 2008
Story Timeline: 155 days
Clarient, Inc. (NASDAQ:CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, announced preliminary financial results for the first quarter ended March 31, 2008. Revenue from continuing operations was $15.9...
[read full story]